Bronchial Diseases News

Bronchial Diseases	Welcome, Profile Billing Logout

12 3 4 5 6 7 8 9 10 11 12 13...51 52 »

|||||||||| Trial termination: Self Management Education Asthma (clinicaltrials.gov) - Mar 12, 2024
P=N/A, N=0, Terminated, Sponsor: University of New Mexico
Completed --> Terminated; Not a clinical trial and was inadvertently entered in the system.

|||||||||| Trial completion, Enrollment change: AsthMaP2: Vitamin D, Steroids, and Asthma in African American Youth (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=273, Completed, Sponsor: Robert J. Freishtat
Completed --> Terminated; Not a clinical trial and was inadvertently entered in the system. Active, not recruiting --> Completed | N=500 --> 273

||||||||||  Fludase (oplunofusp) / Ansun Biopharma
Trial completion, Enrollment change:  A Safety Trial of DAS181 (Fludase (clinicaltrials.gov) -  Apr 20, 2019
P1, N=11, Completed,  Sponsor: Ansun Biopharma, Inc.
Active, not recruiting --> Completed | N=500 --> 273 Recruiting --> Completed | N=24 --> 11

|||||||||| Trial completion: Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=44, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Completed | N=24 --> 11 Active, not recruiting --> Completed

||||||||||  ipratropium bromide / Generic mfg.
Trial completion:  Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus (clinicaltrials.gov) -  Apr 18, 2019
P1, N=30, Completed,  Sponsor: University Hospitals Cleveland Medical Center
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| Trial completion: Optimizing Vitamin D Status in Children With Wheeze / Asthma (OPTIVIT) (clinicaltrials.gov) - Apr 8, 2019
P=N/A, N=40, Completed, Sponsor: Queen Mary University of London
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion, Trial completion date, Trial primary completion date: CRADL: Continuous Regional Analysis Device for Neonate Lung (clinicaltrials.gov) - Mar 21, 2019
P=N/A, N=200, Completed, Sponsor: University of Schleswig-Holstein
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2019 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Airway Pressure During Humidified High Flow Nasal Cannula Therapy in Children (clinicaltrials.gov) - Mar 6, 2019
P=N/A, N=40, Completed, Sponsor: McMaster University
Recruiting --> Completed | Trial completion date: Dec 2019 --> Mar 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 Recruiting --> Completed | Trial completion date: Jun 2016 --> Dec 2016 | Trial primary completion date: Jun 2016 --> Dec 2016

|||||||||| Enrollment change, Trial termination: Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract (clinicaltrials.gov) - Mar 5, 2019
P2, N=3, Terminated, Sponsor: Laboratorios Leti, S.L.
Recruiting --> Completed | Trial completion date: Jun 2016 --> Dec 2016 | Trial primary completion date: Jun 2016 --> Dec 2016 N=90 --> 3 | Suspended --> Terminated; Lack of recruitment

||||||||||  fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Phase classification:  Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. (clinicaltrials.gov) -  Feb 26, 2019
P1/2, N=60, Completed,  Sponsor: GlaxoSmithKline
N=90 --> 3 | Suspended --> Terminated; Lack of recruitment Phase classification: P2 --> P1/2

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Asthmatuner a Self-management App for Asthma: A Randomized Controlled Multicentre Trial (clinicaltrials.gov) - Feb 21, 2019
P=N/A, N=77, Completed, Sponsor: Karolinska Institutet
Phase classification: P2 --> P1/2 Recruiting --> Completed | N=43 --> 77 | Trial completion date: Dec 2017 --> Feb 2019 | Trial primary completion date: Dec 2017 --> Aug 2018

||||||||||  acetylcysteine solution / Generic mfg.
Trial completion, Phase classification, Trial completion date, Trial primary completion date:  BENE: Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis (clinicaltrials.gov) -  Feb 18, 2019
P=N/A, N=161, Completed,  Sponsor: Qilu Hospital of Shandong University
Recruiting --> Completed | N=43 --> 77 | Trial completion date: Dec 2017 --> Feb 2019 | Trial primary completion date: Dec 2017 --> Aug 2018 Active, not recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Dec 2016 --> Mar 2018 | Trial primary completion date: Sep 2016 --> Dec 2017

||||||||||  carbon dioxide/perflubron (S1226) / SolAeroMed
Trial completion:  S-1226(8%): Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma (clinicaltrials.gov) -  Feb 18, 2019
P2a, N=12, Completed,  Sponsor: SolAeroMed Inc.
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A | Trial completion date: Dec 2016 --> Mar 2018 | Trial primary completion date: Sep 2016 --> Dec 2017 Recruiting --> Completed

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Sleep Apnea in Asthmatic Children and Teenagers (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=80, Completed, Sponsor: Federal University of São Paulo
Recruiting --> Completed Recruiting --> Completed | Trial completion date: Nov 2017 --> Sep 2018 | Trial primary completion date: Nov 2017 --> Sep 2018

|||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma (clinicaltrials.gov) - Feb 8, 2019
P=N/A, N=3, Terminated, Sponsor: Centre Hospitalier Universitaire Saint Pierre
Recruiting --> Completed | Trial completion date: Nov 2017 --> Sep 2018 | Trial primary completion date: Nov 2017 --> Sep 2018 N=40 --> 3 | Trial completion date: Aug 2017 --> Aug 2018 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Aug 2018; methodological concerns about study design

|||||||||| Trial completion, Trial primary completion date: The Use of Home-monitoring and mHealth Systems to Predict Asthma Control and the Occurrence of Asthma Exacerbations (clinicaltrials.gov) - Feb 7, 2019
P=N/A, N=150, Completed, Sponsor: Manchester University NHS Foundation Trust
N=40 --> 3 | Trial completion date: Aug 2017 --> Aug 2018 | Recruiting --> Terminated | Trial primary completion date: Aug 2017 --> Aug 2018; methodological concerns about study design Not yet recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jul 2018

|||||||||| Enrollment change, Trial completion date, Trial initiation date, Trial withdrawal, Trial primary completion date: AUDIT: Description of the Ability to Learn How to Handle Inhaler Devices in Asthma (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=0, Withdrawn, Sponsor: University Hospital, Bordeaux
Not yet recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jul 2018 N=30 --> 0 | Trial completion date: Mar 2018 --> Sep 2018 | Initiation date: Jul 2017 --> Dec 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2018 --> Sep 2018

|||||||||| Enrollment change: A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects (clinicaltrials.gov) - Jan 31, 2019
P2b, N=0, Withdrawn, Sponsor: Pfizer
N=30 --> 0 | Trial completion date: Mar 2018 --> Sep 2018 | Initiation date: Jul 2017 --> Dec 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2018 --> Sep 2018 N=350 --> 0

||||||||||  carbocisteine / Generic mfg.
Trial completion:  Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup (clinicaltrials.gov) -  Jan 30, 2019
P1, N=30, Completed,  Sponsor: Domp
N=350 --> 0 Active, not recruiting --> Completed

|||||||||| Trial completion: APOLO: Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice (clinicaltrials.gov) - Jan 25, 2019
P=N/A, N=152, Completed, Sponsor: Roxall Medicina España S.A
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: AVAD: Asthma With Small Airways Dysfunction (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=11, Terminated, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed N=100 --> 11 | Trial completion date: Mar 2019 --> Jul 2017 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Jul 2017; difficulties of enrollment

||||||||||  Depigoid Birch (depigmented glutaraldehyde polymerized birch pollen allergenic extract) / Leti Pharma
Trial completion, Trial primary completion date:  Depigoid Birch 5000 Longterm Study in Adults and Adolescents (clinicaltrials.gov) -  Jan 17, 2019
P3, N=634, Completed,  Sponsor: Leti Pharma GmbH
N=100 --> 11 | Trial completion date: Mar 2019 --> Jul 2017 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Jul 2017; difficulties of enrollment Active, not recruiting --> Completed | Trial primary completion date: May 2018 --> Jul 2018

||||||||||  aspirin / Generic mfg.
Trial completion:  High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) (clinicaltrials.gov) -  Jan 17, 2019
P=N/A, N=10, Completed,  Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed | Trial primary completion date: May 2018 --> Jul 2018 Recruiting --> Completed

|||||||||| Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date: Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses (clinicaltrials.gov) - Jan 14, 2019
P=N/A, N=44, Active, not recruiting, Sponsor: University of Wisconsin, Madison
Recruiting --> Completed Recruiting --> Active, not recruiting | N=30 --> 44 | Trial completion date: Mar 2018 --> Jun 2019 | Trial primary completion date: Mar 2018 --> Aug 2017

|||||||||| Trial completion, Enrollment change: BioAce: Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics (clinicaltrials.gov) - Jan 4, 2019
P=N/A, N=68, Completed, Sponsor: Fred Wamboldt, MD
Recruiting --> Active, not recruiting | N=30 --> 44 | Trial completion date: Mar 2018 --> Jun 2019 | Trial primary completion date: Mar 2018 --> Aug 2017 Active, not recruiting --> Completed | N=120 --> 68

|||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: High Flow Nasal Cannula Use in Infants With Bronchiolitis (clinicaltrials.gov) - Dec 20, 2018
P=N/A, N=18, Terminated, Sponsor: University of Oulu
Active, not recruiting --> Completed | N=120 --> 68 N=160 --> 18 | Trial completion date: Mar 2020 --> Sep 2018 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Sep 2018; Slow recruitment

|||||||||| Trial completion, Trial completion date, Trial primary completion date: AsthmaDom: Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study (clinicaltrials.gov) - Dec 13, 2018
P=N/A, N=120, Completed, Sponsor: University Hospital, Bordeaux
N=160 --> 18 | Trial completion date: Mar 2020 --> Sep 2018 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Sep 2018; Slow recruitment Recruiting --> Completed | Trial completion date: Nov 2017 --> Nov 2018 | Trial primary completion date: Nov 2017 --> Nov 2018

|||||||||| Enrollment change, Trial initiation date, Trial withdrawal: ASANX: Biofeedback for Asthma Comorbid With Anxiety or Depression (clinicaltrials.gov) - Dec 12, 2018
P=N/A, N=0, Withdrawn, Sponsor: Rutgers, The State University of New Jersey
Recruiting --> Completed | Trial completion date: Nov 2017 --> Nov 2018 | Trial primary completion date: Nov 2017 --> Nov 2018 N=20 --> 0 | Initiation date: Jan 2018 --> Dec 2018 | Not yet recruiting --> Withdrawn

||||||||||  itepekimab (SAR440340) / Sanofi, Regeneron
Trial completion, Trial primary completion date:  Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma (clinicaltrials.gov) -  Dec 12, 2018
P1, N=23, Completed,  Sponsor: Regeneron Pharmaceuticals
N=20 --> 0 | Initiation date: Jan 2018 --> Dec 2018 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed | Trial primary completion date: May 2018 --> Aug 2018

||||||||||  methylprednisolone oral / Generic mfg.
Phase classification, Enrollment change:  A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients (clinicaltrials.gov) -  Nov 29, 2018
P=N/A, N=0, Withdrawn,  Sponsor: Pfizer
Active, not recruiting --> Completed | Trial primary completion date: May 2018 --> Aug 2018 Phase classification: P4 --> P=N/A | N=100 --> 0

|||||||||| Trial completion date, Trial primary completion date: AVAD: Asthma With Small Airways Dysfunction (clinicaltrials.gov) - Nov 23, 2018
P=N/A, N=100, Recruiting, Sponsor: Hospices Civils de Lyon
Phase classification: P4 --> P=N/A | N=100 --> 0 Trial completion date: Mar 2018 --> Mar 2019 | Trial primary completion date: Mar 2018 --> Mar 2019

||||||||||  Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date, Adherence:  Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice. (clinicaltrials.gov) -  Nov 16, 2018
P=N/A, N=0, Withdrawn,  Sponsor: Mundipharma Pharmaceuticals B.V.
Trial completion date: Mar 2018 --> Mar 2019 | Trial primary completion date: Mar 2018 --> Mar 2019 N=250 --> 0 | Trial completion date: Nov 2018 --> Dec 2016 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2018 --> Dec 2016

|||||||||| Trial completion: HIIT-BAC: The Houston HIITBAC for African Americans (clinicaltrials.gov) - Nov 15, 2018
P=N/A, N=264, Completed, Sponsor: Baylor College of Medicine
N=250 --> 0 | Trial completion date: Nov 2018 --> Dec 2016 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2018 --> Dec 2016 Active, not recruiting --> Completed

||||||||||  azelastine intranasal / Generic mfg., fluticasone / Generic mfg.
Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  MAN06: Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis (clinicaltrials.gov) -  Oct 31, 2018
P4, N=7, Terminated,  Sponsor: University of Dundee
Active, not recruiting --> Completed N=20 --> 7 | Trial completion date: Jun 2019 --> Sep 2018 | Recruiting --> Terminated | Trial primary completion date: Jun 2019 --> Sep 2018; The company providing study IMP was unable to supply further batches of IMP.

||||||||||  fluticasone / Generic mfg.
Trial completion, Heterogeneity:  EXPAND: Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma (clinicaltrials.gov) -  Oct 25, 2018
P4, N=31, Completed,  Sponsor: University of Virginia
N=20 --> 7 | Trial completion date: Jun 2019 --> Sep 2018 | Recruiting --> Terminated | Trial primary completion date: Jun 2019 --> Sep 2018; The company providing study IMP was unable to supply further batches of IMP. Enrolling by invitation --> Completed

|||||||||| Enrollment closed, Trial completion date, Trial primary completion date: Optimizing Vitamin D Status in Children With Wheeze / Asthma (OPTIVIT) (clinicaltrials.gov) - Oct 22, 2018
P=N/A, N=40, Active, not recruiting, Sponsor: Queen Mary University of London
Enrolling by invitation --> Completed Recruiting --> Active, not recruiting | Trial completion date: Jul 2018 --> Feb 2019 | Trial primary completion date: Jul 2018 --> Feb 2019

|||||||||| Enrollment change, Trial termination, Trial primary completion date: Cough Assist in Bronchiolitis (clinicaltrials.gov) - Oct 16, 2018
P=N/A, N=1, Terminated, Sponsor: University Hospital, Antwerp
Recruiting --> Active, not recruiting | Trial completion date: Jul 2018 --> Feb 2019 | Trial primary completion date: Jul 2018 --> Feb 2019 N=20 --> 1 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Oct 2018; Difficulties with patient inclusion

|||||||||| Trial completion, Trial completion date: Improving Parent Understanding of Instructions About Asthma Care (clinicaltrials.gov) - Oct 5, 2018
P=N/A, N=449, Completed, Sponsor: New York University School of Medicine
N=20 --> 1 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Oct 2018; Difficulties with patient inclusion Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Mar 2018

|||||||||| Trial completion: Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Oct 3, 2018
P=N/A, N=445, Completed, Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Mar 2018 Active, not recruiting --> Completed

|||||||||| Trial completion: Telephone Coaches to Improve Control of Asthma in Children ( PARTNER) Study) (clinicaltrials.gov) - Oct 3, 2018
P=N/A, N=984, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: ASIST: Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children (clinicaltrials.gov) - Oct 2, 2018
P4, N=206, Completed, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: SB-TEAM: School-Based Telemedicine Enhanced Asthma Management (clinicaltrials.gov) - Sep 28, 2018
P=N/A, N=400, Completed, Sponsor: University of Rochester
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion, Enrollment change: Within-day and Between-day Repeatability of the Breath Pattern in Healthy Children and in Children With Asthma (clinicaltrials.gov) - Sep 5, 2018
P=N/A, N=45, Completed, Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Active, not recruiting --> Completed Recruiting --> Completed | N=120 --> 45

||||||||||  Plivensia (sirukumab) / J&J
Trial completion date, Trial primary completion date:  A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma (clinicaltrials.gov) -  Aug 31, 2018
P2a, N=0, Withdrawn,  Sponsor: GlaxoSmithKline
Recruiting --> Completed | N=120 --> 45 Trial completion date: Jul 2017 --> Oct 2016 | Trial primary completion date: Jul 2017 --> Oct 2016

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Evaluation of a Community Pharmacist Managed Asthma Consultation Service (clinicaltrials.gov) - Aug 28, 2018
P=N/A, N=19, Completed, Sponsor: Zahava Rosenberg-Yunger
Trial completion date: Jul 2017 --> Oct 2016 | Trial primary completion date: Jul 2017 --> Oct 2016 Active, not recruiting --> Completed | N=105 --> 19 | Trial completion date: Sep 2018 --> Apr 2018 | Trial primary completion date: Sep 2017 --> Apr 2018

|||||||||| Trial completion, Enrollment change: A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department (clinicaltrials.gov) - Aug 17, 2018
P=N/A, N=1102, Completed, Sponsor: Vanderbilt University Medical Center
Active, not recruiting --> Completed | N=105 --> 19 | Trial completion date: Sep 2018 --> Apr 2018 | Trial primary completion date: Sep 2017 --> Apr 2018 Enrolling by invitation --> Completed | N=400 --> 1102

|||||||||| Enrollment change, Trial completion date, Trial primary completion date: A Computerized Asthma Management System in the Pediatric Emergency Department (clinicaltrials.gov) - Aug 17, 2018
P=N/A, N=1631, Completed, Sponsor: Vanderbilt University Medical Center
Enrolling by invitation --> Completed | N=400 --> 1102 N=2400 --> 1631 | Trial completion date: Feb 2011 --> Dec 2015 | Trial primary completion date: Feb 2011 --> Dec 2015

|||||||||| Trial completion: SBRCTHILARBA: Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma (clinicaltrials.gov) - Aug 16, 2018
P=N/A, N=100, Completed, Sponsor: Mahesh Bhattacharyya Homoeopathic Medical College and Hospital
N=2400 --> 1631 | Trial completion date: Feb 2011 --> Dec 2015 | Trial primary completion date: Feb 2011 --> Dec 2015 Active, not recruiting --> Completed

|||||||||| Trial completion, Trial completion date: Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma (clinicaltrials.gov) - Aug 8, 2018
P2b, N=57, Completed, Sponsor: Laboratorios Leti, S.L.
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Jun 2018

|||||||||| Phase classification: Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT) (clinicaltrials.gov) - Aug 8, 2018
P=N/A, N=52, Completed, Sponsor: University of Chicago
Active, not recruiting --> Completed | Trial completion date: Mar 2019 --> Jun 2018 Phase classification: P2 --> P=N/A



	Diseases Companies Products Productz Mechanisms of Action Sites